Nagao Kanetsugu, Yamashita Shigeyuki, Ebe Rina, Naruto Norihito, Ito Hisakatsu, Nagura Saori, Doi Toshio, Fukahara Kazuaki, Yoshimura Naoki
First Department of Surgery, University of Toyama, Toyama, Toyama, Japan.
Department of Radiology, University of Toyama, Toyama, Toyama, Japan.
Ann Vasc Dis. 2023;16(4):273-276. doi: 10.3400/avd.avd.cr.23-00060. Epub 2023 Oct 11.
Antithrombotic agents are increasingly prescribed to older adults; however, they are associated with bleeding-related complications. We describe a case of intraoperative heparin resistance after administration of andexanet alfa (AA). An 81-year-old man was diagnosed with a ruptured internal iliac artery aneurysm. The patient required emergency endovascular aneurysm repair and was treated with AA because he was receiving apixaban. Despite high-dose intraoperative heparin administration, his activated coagulation time was not prolonged. Our findings suggest that AA should be administered with caution in patients experiencing potentially fatal bleeding (requiring surgical intervention) who are also receiving direct oral anticoagulants.
抗血栓药物越来越多地被开给老年人;然而,它们与出血相关的并发症有关。我们描述了一例使用安多昔单抗(AA)后出现术中肝素抵抗的病例。一名81岁男性被诊断为髂内动脉瘤破裂。该患者需要紧急进行血管内动脉瘤修复,由于他正在服用阿哌沙班,因此接受了AA治疗。尽管术中给予了高剂量肝素,但他的活化凝血时间并未延长。我们的研究结果表明,对于同时接受直接口服抗凝剂且发生潜在致命性出血(需要手术干预)的患者,应谨慎使用AA。